tiprankstipranks
Advertisement
Advertisement

Ceres Takes Control of SQUIZ to Expand Online Healthcare Platform

Story Highlights
  • Ceres acquires 90% of online medical platform SQUIZ to deepen digital healthcare reach.
  • Deal aims to boost D2C healthcare services, drive synergies, and preserve Mandom partnership.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Ceres Takes Control of SQUIZ to Expand Online Healthcare Platform

Meet Samuel – Your Personal Investing Prophet

CERES INC. ( (JP:3696) ) has provided an update.

Ceres Inc. has moved to deepen its presence in online healthcare by acquiring a 90 percent stake in SQUIZ Co., Ltd., an online medical platform, for ¥3.6 billion as of April 1, 2026. This transaction follows a minority investment made in July 2022, and is accompanied by a ¥300 million allotment of treasury shares to key SQUIZ managers to align incentives.

The company aims to use SQUIZ to strengthen its D2C and online healthcare platform business and to generate synergies across its vertically integrated Mobile Services model. Ceres also intends to maintain its existing partnership framework with Mandom through a shareholders’ agreement, underscoring the strategic nature of this acquisition for broader industry collaboration and future growth.

The most recent analyst rating on (JP:3696) stock is a Buy with a Yen1611.00 price target. To see the full list of analyst forecasts on CERES INC. stock, see the JP:3696 Stock Forecast page.

More about CERES INC.

Ceres Inc., listed on the TSE Prime Market under ticker 3696, operates in mobile and digital services with a focus on direct-to-consumer and online platform businesses. The company pursues a vertically integrated Mobile Services model and seeks strategic investments that enhance its presence in online healthcare and related digital ecosystems.

Average Trading Volume: 171,679

Technical Sentiment Signal: Sell

Current Market Cap: Yen16.39B

For an in-depth examination of 3696 stock, go to TipRanks’ Overview page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1